期刊文献+

萘普生固体分散体的研制

Preparation of naproxen solid dispersion
下载PDF
导出
摘要 目的 制备萘普生-聚乙二醇6000(PEG6000)固体分散体,分析萘普生药物溶出速率和溶解度.方法 萘普生与PEG6000按照不同的的质量比例,采用熔融法制备固体分散体;通过紫外光谱、红外光谱、体外溶出及溶解度检测对固体分散体进行分析.结果 紫外光谱和红外光谱均验证固体分散体的形成.与萘普生原料药相比,萘普生固体分散体的溶出速率和溶解度均提高.结论 萘普生-PEG6000固体分散体能显著提高萘普生溶出速率和溶解度,且随着载体比例的增大,溶出速率和溶解度也增大. Objective To prepare solid dispersions of naproxen with polyethylene glycol 6000 (PEG6000) to improve its dissolution and solubility. Methods The solid dispersions of naproxen were prepared by the fusion method with PEG6000 as the carrier. Evaluation of the properties of the dispersions was performed by ultraviolet spectroscopy, infrared spectroscopy, dissolution and solubility studies. Results There was no new substance produced by naproxen and PEG6000. Compared with crude drug, the dissolution rate and the solubility of solid dispersions were increased immensely. Conclusion The dissolution and solubility of naproxen can be improved significantly in solid dispersion with PEG6000. With the increase of the proportion of the carrier, the dissolution rate and solubility of solid dispersions be- come greater.
出处 《徐州医学院学报》 CAS 2012年第2期88-91,共4页 Acta Academiae Medicinae Xuzhou
关键词 萘普生 聚乙二醇6000 固体分散体 溶出速率 溶解度 naproxen polyethylene glycol 6000 solid dispersion dissolution rate solubility
  • 相关文献

参考文献6

  • 1国家药典委员会.中华人民共和国药典2010版·二部[S]北京:中国医药科技出版社,2010873.
  • 2周全.固体分散体制备技术[A]北京:人民卫生出版社,20053.
  • 3Shah J,Vasanti S,Anroop B. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000:preparation and in vitro evaluation[J].Journal of Inclusion Phenomena and Macrocyclic Chemistry,2009.69-75.
  • 4王展,韩立炜,任天池.葛根素-聚乙二醇6000固体分散体的制备及其溶解性能的研究[J].北京中医药大学学报,2007,30(5):346-349. 被引量:17
  • 5国家药典委员会.中华人民共和国药典2010版·二部[S]北京:中国医药科技出版社,2010附录86.
  • 6李标.固体分散体在药剂学中的应用[J].中国药房,2009,20(10):790-792. 被引量:15

二级参考文献26

  • 1秦文,董兴兵,杨勤.葛根素的临床应用新进展[J].中国药业,2004,13(7):75-76. 被引量:13
  • 2吴燕红,苏子仁,赖小平,林吉.愈风宁心片中葛根素在Beagle犬体内药动学研究[J].中成药,2006,28(2):215-218. 被引量:12
  • 3陈鹰,陈松,覃贝,王瑞华,李高.固体分散体技术改善长春西汀溶出特性的研究[J].广东药学院学报,2007,23(3):259-262. 被引量:3
  • 4Saito M, Uqajin T, Nozawa Y, et al. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides[J ]. Int J Phar, 2002,249( 1-- 2) : 71.
  • 5陆彬主编.药物新剂型与新制剂[M].北京:人民卫生出版社,1998:1-23.
  • 6Gines JM, Arias MJ, Moyano JR, et al. Thermal investigation of crystallization of poly(ethylene glycol) s in solid dispersions containing oxazepam[J]. Int J Pharm , 1996, 143(11) :247.
  • 7McGinity JW, Maincent P, Steinfink H. Crystallinity and dissolution rata of tolbutamide solid dispersion prepared by the melt method[J ] .J Pharm Sci, 1984, 73 (10) : 1 441.
  • 8Ozeki T, Yuasa H, Kanaya Y. Mechanism of medicine release from solid dispersion composed of Poly(ethylene oxide) - carboxyvinylpolymer interpolymer complex and pH effcct on medicine release[J]. Int J Pharm, 1998, 171(1) : 123.
  • 9Ozeki T, Yuasa H, Kanaya Y .Control of medicine releasefrom solid dispersion composed of the poly(ethylene oxide) - carboxyvinylpolymer interpolymercomplex by varying molecular weight of poly(ethylene oxide)[J].J Controlled Release, 1999,58(1) : 87.
  • 10Ozeki T, Yuasa H, Kanaya Y. Controlled release from solid dispersion composed of poly(ethylene oxide) - Carbopol ^ interpolymer complex with variouscross- linking degrees of Carbopoly^ [J ] .J Controlled Release, 2000, 63(3) :287.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部